Top Markets
Coin of the day
Bioqual, Inc. Bioqual, Inc.

Bioqual, Inc.

BIOQ
Ранг среди акций #28014
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
Цена акции
$32.50
Последняя синхронизация: 2026-08-18
Рыночная капитализация
$29.07M
Изменение (1 день)
0.00%
Изменение (1 год)
-24.75%
Страна
US
Торговля Bioqual, Inc. (BIOQ)

Категория

EPS для Bioqual, Inc. (BIOQ)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Bioqual, Inc., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Bioqual, Inc. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US